Dr Kieran Joyce

RCSI Millin Surgical Innovation Award for Rinn Medical Devices Researcher

Thursday November 19th

Dr Kieran Joyce, an orthopaedic surgical registrar and postdoctoral researcher at Rinn Medical Devices at University of Galway, has been awarded the prestigious RCSI Millin Surgical Innovation Award at the 2026 RCSI Millin Meeting, held in Dublin on 13 November.

The award recognises excellence in surgical research and is presented for the best oral research presentation at the national meeting, which brings together surgeons, surgical trainees, clinician-scientists and researchers from across Ireland.

Dr Joyce received the award for his presentation entitled “Targeting sialylation attenuates disc degeneration and restores the nucleus pulposus glycome after nucleotomy.”

The research was undertaken at CÚRAM, the Research Ireland Centre for Medical Devices, (predecessor of Rinn Medical Devices), under the mentorship of Professor Abhay Pandit, and represents a multidisciplinary programme integrating orthopaedic surgery, biomaterials science, glycobiology and regenerative medicine.

Intervertebral disc degeneration is a major contributor to chronic lower back pain and spinal disability. Current surgical treatments can alleviate symptoms but do not restore the underlying biological structure or function of the damaged disc.

The award-winning research investigates a novel regenerative strategy based on modulating glycosylation, the biological process through which sugar molecules are attached to proteins and other cellular structures.

Specifically, the work examines how targeting sialylation, a form of glycosylation involving sialic acids, can influence the biological response of intervertebral disc tissue following injury.

Using advanced glycomic, proteomic and molecular techniques, alongside preclinical models of intervertebral disc injury, the researchers demonstrated that modulation of sialylation could attenuate degenerative changes and help restore the glycosylation profile of the nucleus pulposus, the central region of the intervertebral disc.

These findings identify glycosylation as a promising therapeutic target and provide a foundation for developing novel biomaterial-based interventions aimed at preserving or restoring disc health following injury or surgery.

The project reflects the translational research ethos of Rinn Medical Devices, combining fundamental biological discoveries with clinically relevant approaches to addressing unmet needs in musculoskeletal medicine.

Millin Meeting

The 2026 RCSI Millin Meeting was held under the theme “Research and Innovation in Surgery”, bringing together Ireland’s surgical and research communities to discuss the future of surgical innovation, clinical trials and translational research.

The programme highlighted the development of national surgical research infrastructure, including the National Surgical Research Support Centre and the Irish Surgical Trials and Research (I-STAR) Network.

Commenting on the award Dr Joyce said  “I am honoured to receive the RCSI National Surgical Research Medal and to have the opportunity to showcase this research. Our work highlights the potential of targeting glycosylation as a novel therapeutic strategy for intervertebral disc degeneration, with the longer-term aim of translating these discoveries into treatments that improve patient outcomes.

The Millin Meeting was a fantastic opportunity to engage with an enthusiastic and ambitious community of surgeon-scientists, united by a clear commitment to advancing translational research and surgical clinical trials in Ireland. It was an incredibly motivating experience, and I am grateful to be part of a community so dedicated to translating scientific innovation into meaningful improvements in patient care.”

Ends.

all News
Back to Top